Switzerland
ADC Therapeutics gathers $76m in series-E extension
Headquartered in Lausanne, ADC Therapeutics has raised $531m since its inception in 2012
CIC backs Mega Gossau
CIC Capital has acquired a minority stake with the management team retaining a majority
Wineus Capital acquires Zurrfix
Wineus typically provides investments of between CHF 5-30m for SMEs in Switzerland
DACH manufacturing slump puts strain on deal-doing
With confidence hitting a low point in DACH's manufacturing sector, PE investors have to navigate a winding road to find opportunities
Ekkio backs Mediliant
Mediliant is the fourth investment completed via Ekkio Capital IV, closed in May 2018
Ardian acquires Sintetica
In 2018, Sintetica reported revenues of CHF 75m, up from approximately CHF 60m in 2017
Capvis acquires Xovis from Emeram
Emeram and the management team invested in Xovis in 2016, with Emeram taking a majority stake
EQT, ADIA to acquire Nestlé Skin Health in CHF 10.2bn deal
Auction process saw KKR, a consortium of Advent International and Cinven, and Unilever as bidders
Buy-and-build drives consolidation in DACH
Last year saw the second highest volume of bolt-on deals in the DACH region in the post-2008 era
VCs sell Therachon to Pfizer for $810m
Pfizer will acquire Therachon for $340m with $470m in additional, conditional payments
Panakès Partners in CHF 9.5m round for SamanTree
Panakès Partners is using equity from its Fund I, which invests €5-6m in European startups
Consortium invests CHF 12.5m in Alentis
BioMedPartners, BB Pureos Bioventures, BPI France, Schroder Adveq and HTGF participate in the deal
Unigestion launches second direct investment vehicle
Predecessor fund held a €255m final close in 2017 after 21 months on the road
Battery Ventures-backed AED-Sicad acquires Geocom
Geocom and AED-Sicad will merge and the combined company will operate under a new brand
Ardian to acquire Sintetica
Sintetica recorded revenue of approximately €60m for 2018 and employs around 300 staff
RRJ Capital acquires GateGroup from HNA
GateGroup was acquired by HNA Group and de-listed from the SIX Swiss Exchange in 2016
Aurelius exits Granovit
Management led by CEO Andreas Fischer will continue to operationally restructure Granovit
Sofinnova, NEA in CHF 22.5m funding round for Polyneuron
Polyneuron develops biodegradable glycopolymers for the treatment of autoimmune diseases
Ufenau holds €560m close for Ufenau VI German Asset Light
Investors include Banque Pictet & Cie, Argentum Fondsinvesteringer and Wave Management
IK supports Klingel's acquisitions of Bächler, Gehring
Klingel is an IK VIII fund company and was acquired by the firm in 2018 from Halder
Nordic GPs set their sights on the DACH region
Nordic buyout houses are increasing their presence in the region, both in terms of deal activity and boots on the ground
Pureos Bioventures leads CHF 10m series-A for NovaGo
Swiss clinical-stage biotech company Neurimmune also takes part in the investment
Syncona leads CHF 35m series-A for Anaveon
Anaveon initially received seed funding from the UZH Life Sciences Fund and BaseLaunch
PG Impact Investments holds $210m final close
Firm is independent but has access to Partners Group’s infrastructure, expertise and resources